CL2018002344A1 - Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina - Google Patents

Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina

Info

Publication number
CL2018002344A1
CL2018002344A1 CL2018002344A CL2018002344A CL2018002344A1 CL 2018002344 A1 CL2018002344 A1 CL 2018002344A1 CL 2018002344 A CL2018002344 A CL 2018002344A CL 2018002344 A CL2018002344 A CL 2018002344A CL 2018002344 A1 CL2018002344 A1 CL 2018002344A1
Authority
CL
Chile
Prior art keywords
pyrrolo
preparing
pyrimidine compounds
pirrolo
methyl
Prior art date
Application number
CL2018002344A
Other languages
English (en)
Inventor
Timothy Lee Stuk
Denis Billen
Valerie Sue Westrick
Vageesha Warnajith Liyana Gunawardana
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of CL2018002344A1 publication Critical patent/CL2018002344A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/19—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EN LA PRESENTE SE DESCRIBEN PROCESOS MEJORADOS PARA LA PREPARACIÓN DEL COMPUESTO DE 7H-PIRROLO[2,3-D]PIRIMIDINA, N-METIL-1- {TRANS-4-[METIL(7H-PIRROLO[2,3-D]PIRIMIDIN-4-IL)AMINO]CICLOHEXIL}-METANOSULFONAMIDA, INTERMEDIOS DE ESTOS Y SALES VETERINARIAMENTE ACEPTABLES DE ESTOS (FÓRMULA (1)).
CL2018002344A 2016-02-16 2018-08-16 Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina CL2018002344A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662295739P 2016-02-16 2016-02-16
US201662375040P 2016-08-15 2016-08-15

Publications (1)

Publication Number Publication Date
CL2018002344A1 true CL2018002344A1 (es) 2018-09-14

Family

ID=58018338

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002344A CL2018002344A1 (es) 2016-02-16 2018-08-16 Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina

Country Status (15)

Country Link
US (1) US9926327B2 (es)
EP (1) EP3416965B1 (es)
JP (1) JP6568324B2 (es)
KR (1) KR102124449B1 (es)
CN (1) CN108699072B (es)
AU (1) AU2017221193B2 (es)
BR (1) BR112018016708B1 (es)
CA (1) CA3012589C (es)
CL (1) CL2018002344A1 (es)
CO (1) CO2018008253A2 (es)
MX (1) MX2018009912A (es)
NZ (1) NZ744341A (es)
RU (1) RU2699034C1 (es)
WO (1) WO2017142740A1 (es)
ZA (1) ZA201804871B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2022471B1 (en) * 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib
EP3915989B1 (en) * 2019-01-30 2023-06-28 FelicaMed Biotechnology Co., Ltd Jak inhibitor and preparation method therefor
US20220274992A1 (en) * 2019-08-26 2022-09-01 Chemwerth, Inc. Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl) amino compounds useful as jak 1 inhibitors
CN112279854B (zh) * 2020-08-25 2022-04-05 常州齐晖药业有限公司 一种7H-吡咯并[2,3-d]嘧啶化合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424213A (en) 1980-11-10 1984-01-03 Sds Biotech Corporation Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
CZ20004727A3 (cs) 1998-06-19 2002-03-13 Pfizer Products Inc. Deriváty pyrrolo[2,3-d] pyrimidinu
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
US8193206B2 (en) 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
EP1913000B1 (en) 2005-07-29 2012-01-11 Pfizer Products Inc. Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
JP4884570B2 (ja) * 2008-08-20 2012-02-29 ファイザー・インク ピロロ［２，３−ｄ］ピリミジン化合物
AU2010308028A1 (en) * 2009-10-15 2012-04-19 Pfizer Inc. Pyrrolo[2,3-d] pyrimidine compounds
JP5739446B2 (ja) * 2009-12-18 2015-06-24 ファイザー・インク ピロロ［２，３−ｄ］ピリミジン化合物
KR101484382B1 (ko) * 2010-02-24 2015-01-19 조에티스 엘엘씨 수의학적 조성물

Also Published As

Publication number Publication date
CO2018008253A2 (es) 2018-08-21
BR112018016708A2 (pt) 2018-12-26
NZ744341A (en) 2019-06-28
US20170233397A1 (en) 2017-08-17
KR20180100225A (ko) 2018-09-07
EP3416965B1 (en) 2020-10-07
US9926327B2 (en) 2018-03-27
WO2017142740A1 (en) 2017-08-24
RU2699034C1 (ru) 2019-09-03
EP3416965A1 (en) 2018-12-26
KR102124449B1 (ko) 2020-06-26
MX2018009912A (es) 2018-11-29
CA3012589C (en) 2020-05-05
CN108699072A (zh) 2018-10-23
BR112018016708B1 (pt) 2023-11-07
AU2017221193A1 (en) 2018-08-09
JP2019505547A (ja) 2019-02-28
ZA201804871B (en) 2019-05-29
AU2017221193B2 (en) 2019-03-14
JP6568324B2 (ja) 2019-08-28
CN108699072B (zh) 2021-02-26
CA3012589A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
UY37781A (es) Proceso para la preparación de pirazolo[1,5-a] pirimidinas y sales de las mismas
CL2018003264A1 (es) Procesos para la preparación de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
CL2018002344A1 (es) Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina
UY37927A (es) Proceso para la preparación de 6-(2-hidroxi-2-metilpropoxi)-4-(6-(6-((6-metoxipiridin-3-il)metil)-3,6-diazabiciclo[3.1.1]heptan-3-il)piridin-3-il)pirazolo[1,5-a]piridina-3-carbonitrilo
BR112017013382A2 (pt) método para preparar um composto, composto, e, ácido.
NZ726356A (en) Processes for preparing antiviral compounds
MX2019012927A (es) Sales del inhibidor fosfoinositida 3-cinasa (pi3k) y procesos para su preparacion.
CO2017012403A2 (es) Proceso para preparar 4-amino-piridazinas
WO2016130920A3 (en) Lrrk2 inhibitors and methods of making and using the same
EA201890899A1 (ru) Модуляторы фарнезоидного x-рецептора
AR083797A1 (es) Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
AR094943A1 (es) Pirimidas condensadas sustituidas con trifluorometilo
AR100818A1 (es) N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il)benzamida
BR112018015880A2 (pt) forma cristalina a de agonista de tlr7, método de preparação e uso da mesma
WO2018029711A3 (en) Process for the preparation of venetoclax
UY36737A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
CL2018002094A1 (es) Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario
PH12018501641B1 (en) Tlr7 agonist trifluoroacetate salt and crystalline form b thereof, preparation methods and uses
WO2016063294A3 (en) Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
BR112017024613A2 (pt) Processos e intermediários para a preparação de {1-(etilsulfonil)-3-[4-(7h-pirrolo[2,3-d] pirimidin-4-il)- 1h-pirazol-1-il]azetidin-3-il}acetonitrila
CL2015003196A1 (es) Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor cb2.
CL2015003195A1 (es) Derivados de purina como agonistas del receptor cb2.
IL288080A (en) A process for the preparation of h7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates
CL2021000276A1 (es) Polimorfo cristalino del clorhidrato de 8-bromo-2-(1-metilpiperidin-4-ilamin)-4-(4-fenoxifenilamin)pirido[4,3-d]pirimidin-5(6h)-ona y método para prepararlo.
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof